Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential
Circulation: Cardiovascular Genetics · 2017-10 · 10 (5)
DOI: 10.1161/circgenetics.117.001902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Cardiovascular Genetics, 2017-10. Verfasst von Nathan R Tucker und 19 weiteren Autor:innen. Beteiligte Einrichtung: From the Cardiovascular Research Center (N.R.T., E.V.D., R.R.C., J.Y., W.J.H., H.S.J., V.A.P., L.-C.W., R.W.M., J.L.-M., S.A.L., D.J.M., P.T.E.) and …. Hauptthemen laut MEDLINE: Atrial Fibrillation, Homeodomain Proteins, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background— Atrial fibrillation (AF) affects over 33 million individuals worldwide. Genome-wide association studies have identified at least 30 AF loci, but the mechanisms through which individual variants lead to altered disease risk have remained unclear for the majority of these loci. At the 1q24 locus, we hypothesized that the transcription factor PRRX1 could be a strong candidate gene as it is expressed in the pulmonary veins, a source of AF in many individuals. We sought to identify the molecular mechanism, whereby variation at 1q24 may lead to AF susceptibility. Methods and Results— We sequenced a ≈158 kb region encompassing PRRX1 in 962 individuals with and without AF. We identified a broad region of association with AF at the 1q24 locus. Using in silico prediction and functional validation, we identified an enhancer that interacts with the promoter of PRRX1 in cells of cardiac lineage. Within this enhancer, we identified a single-nucleotide polymorphism, rs577676, which alters enhancer activity in a mouse atrial cell line and in embryonic zebrafish and differentially regulates PRRX1 expression in human left atria. We found that suppression of PRRX1 in human embryonic stem cell–derived cardiomyocytes and embryonic zebrafish resulted in shortening of the atrial action potential duration, a hallmark of AF. Conclusions— We have identified a functional genetic variant that alters PRRX1 expression, ultimately resulting in electrophysiological alterations in atrial myocytes that may promote AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- From the Cardiovascular Research Center (N.R.T., E.V.D., R.R.C., J.Y., W.J.H., H.S.J., V.A.P., L.-C.W., R.W.M., J.L.-M., S.A.L., D.J.M., P.T.E.) and Department of Surgery (G.V.), Massachusetts General Hospital, Boston;…
Förderung
- NHLBI NIH HHS
Zitieren
APA
Tucker, N. R., Dolmatova, E. V., Lin, H., Cooper, R. R., Ye, J., Hucker, W. J., Jameson, H. S., Parsons, V. A., Weng, L. C., Mills, R. W., Sinner, M. F., Imakaev, M., Leyton-Mange, J., Vlahakes, G., Benjamin, E. J., Lunetta, K. L., Lubitz, S. A., Mirny, L., Milan, D. J., & Ellinor, P. T. (2017). Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential. Circulation: Cardiovascular Genetics, 10(5). https://doi.org/10.1161/circgenetics.117.001902
Vancouver
Tucker NR, Dolmatova EV, Lin H, Cooper RR, Ye J, Hucker WJ, et al. Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential. Circulation: Cardiovascular Genetics. 2017;10(5). doi:10.1161/circgenetics.117.001902
BibTeX
@article{Tucker2017,
author = {Tucker, Nathan R and Dolmatova, Elena V and Lin, Honghuang and Cooper, Rebecca R and Ye, Jiangchuan and Hucker, William J and Jameson, Heather S and Parsons, Victoria A and Weng, Lu-Chen and Mills, Robert W and Sinner, Moritz F and Imakaev, Maxim and Leyton-Mange, Jordan and Vlahakes, Gus and Benjamin, Emelia J and Lunetta, Kathryn L and Lubitz, Steven A and Mirny, Leonid and Milan, David J and Ellinor, Patrick T},
title = {Diminished PRRX1 Expression Is Associated With Increased Risk of Atrial Fibrillation and Shortening of the Cardiac Action Potential},
journal = {Circulation: Cardiovascular Genetics},
year = {2017},
volume = {10},
number = {5},
doi = {10.1161/circgenetics.117.001902}
}
EUVIMED